Clinical Trials
All Clinical Trials - Page 18 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05322200Phase 4Unknown
The POST-ACS Study
Semaglutide
- NCT05458856Phase 3Completed
Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate
Gonadorelin
- NCT05514535Phase 3Completed
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
Semaglutide
- NCT06411366Phase 1Completed
Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans
Follistatin
- NCT04998136Phase 3Completed
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Semaglutide
- NCT05498610Phase 1Completed
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
Semaglutide
- NCT05419856Phase 1Completed
Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
Liraglutide
- NCT05486065Phase 2Completed
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
Semaglutide
- NCT05444569Phase 1Completed
A Study of LY3537021 in Healthy Participants
Liraglutide
- NCT05478252Phase 3Completed
A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
Semaglutide
- NCT05433584Phase 4Active Not Recruiting
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Tirzepatide
- NCT06105229N/AUnknown
Clinical Value of Plasma Humanin in Acute Kidney Injury
Humanin
- NCT05469126Phase 1Completed
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
Orforglipron
- NCT05479591N/AWithdrawn
A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
Liraglutide
- NCT05443334N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Semaglutide
- NCT05548647Phase 4Completed
Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
Semaglutide
- NCT05816057Phase 3Completed
A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
Semaglutide
- NCT06525675N/ACompleted
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
Gonadorelin
- NCT05984134Phase 2Completed
Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction
TB-500
- NCT05263388Phase 3Completed
A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation
Gonadorelin
- NCT06390904Phase 2/Phase 3Active Not Recruiting
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
Gonadorelin
- NCT06379113Phase 2/Phase 3Recruiting
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Gonadorelin
- NCT05316935Phase 2/Phase 3Recruiting
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Gonadorelin
- NCT05305794Phase 3Recruiting
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
Semaglutide
- NCT05445232Phase 1Completed
A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
Retatrutide
- NCT05468632N/ACompleted
A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
Semaglutide
- NCT05421338Phase 1Completed
A Study in Healthy Men to Test How BI 456906 is Processed in the Body
Survodutide
- NCT05339529N/ARecruiting
Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
Thymosin-Alpha-1
- NCT05487469N/AUnknown
Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
Thymosin-Alpha-1
- NCT07127315N/ACompleted
Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
Gonadorelin
- NCT05467514Phase 3Completed
Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
Liraglutide
- NCT05400733N/ARecruiting
Prandial Metabolic Phenotype in Adults
KPV
- NCT04174755N/ARecruiting
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
Semaglutide
- NCT05429593Phase 1Completed
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
Semaglutide
- NCT05412004Phase 3Completed
Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
Tirzepatide
- NCT05348122Phase 2Unknown
A Study of TG103 Injection in Type 2 Diabetes Subjects
Dulaglutide
- NCT05407961Phase 1Completed
A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT05320406Phase 2Active Not Recruiting
RElugolix VErsus LeUprolide Cardiac Trial
Gonadorelin
- NCT05456854Phase 1Withdrawn
Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp
Kisspeptin
- NCT05377333Phase 1Completed
A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Dulaglutide
- NCT05397795Phase 3Unknown
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES
Gonadorelin
- NCT05418907N/AUnknown
Exendin PET/CT for Imaging of Paragangliomas
Exenatide
- NCT05459285Phase 1Completed
A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
Dulaglutide
- NCT05313802Phase 1Completed
A Study of LY3502970 in Healthy Overweight and Obese Participants
Orforglipron
- NCT05356104Phase 2Recruiting
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Semaglutide
- NCT05341089Phase 1Completed
A Study of Two Different Formulations of LY3502970 in Healthy Participants
Orforglipron
- NCT06820047N/ACompleted
Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
Semaglutide
- NCT05328843Phase 1Unknown
Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
Exenatide
- NCT05162768Phase 3Completed
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)
Elamipretide
- NCT05296733Phase 1Completed
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
Survodutide